Related Experiment Video

Updated: Apr 5, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K

Are label-free investigations the best approach to drug discovery?

Ye Fang1

  • 1Biochemical Technologies, Science & Technology Division, Corning Incorporated, Corning, NY, USA.

Future Medicinal Chemistry
|August 28, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
antitargetdrug safetydruggabilityhit identificationlabel-free binding techniquelabel-free cell phenotypic techniquelead selectionpolypharmacology

More Related Videos

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

4.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

4.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.7K

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K

Articles linked to this work by shared authors, journal, and citation graph.

Probe and Assay Dependent Pharmacology of Dantrolene Analogues at the GPR35.

ACS medicinal chemistry letters·2026

Multimodal opioid-free anesthesia containing esketamine versus opioid-based anesthesia: a systematic review and meta-analysis.

BMC anesthesiology·2026

Efficacy, tolerability, and safety of 1.5L-lactulose as bowel preparation for patients with inflammatory bowel disease: a randomized, single-blinded trial.

Internal and emergency medicine·2026

Ellagic acid alleviates ulcerative colitis in a GPR35-dependent manner associated with SDH restoration.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

N-Glycosylation and Alzheimer's disease: A 2001-2025 global bibliometric landscape revealing emerging diagnostic trends.

Journal of Alzheimer's disease reports·2026

Renal Tubule-Specific Deletion of Nephrocystin 3 (Nphp3) Causes Infantile Nephronophthisis-like Phenotypes in Mice.

International journal of molecular sciences·2026

Recent advances of GPR40 agonists as potential anti-Alzheimer's agents.

Future medicinal chemistry·2026

Computational drug design, synthesis, acetylcholinesterase inhibition and kinetic evaluation of novel benzothiazole-thiadiazole/oxadiazole derivatives.

Future medicinal chemistry·2026

Synthesis, in vitro and in silico studies of novel N-benzoyl EF24 analogs as potential anticancer agents.

Future medicinal chemistry·2026

Novel piperazine-pyridine conjugates as aldose reductase inhibitors: synthesis, DFT analysis, molecular docking, ADME evaluation, DPPH radical scavenging activity, and in vitro aldose reductase inhibitory activity.

Future medicinal chemistry·2026

New small molecular drug approvals for 2025: clinical applications, mechanism of action, and chemical synthesis.

Future medicinal chemistry·2026

Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development.

Future medicinal chemistry·2026

Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity.

Nature chemical biology·2026

Inhibition of vasculogenic mimicry by 22-benzyloxydaphlongaminone via glycolysis suppression.

The Journal of antibiotics·2026

Integrating Fragment Screening and Covalent Chemistry to Drug DNA-Binding Proteins: RAD52 as a Case Study.

Journal of the American Chemical Society·2026

Outdoor attractive targeted sugar bait Phase III trials for malaria control in Kenya, Mali, and Zambia: An individual participant data meta-analysis.

PLOS global public health·2026

Integrating in vitro and in silico correlation of thiazole-based carboxamide derivatives as promising SARS-CoV-2 papain-like protease inhibitors: a versatile approach for COVID-19 therapy.

Zeitschrift fur Naturforschung. C, Journal of biosciences·2026

AutoHMD: Scalable and Accurate Validation of Antibody-Antigen Complexes by Heated Molecular Dynamics.

Bioinformatics (Oxford, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us